SNN (smith-nephew.com) Quick Liquidity

A balanced portfolio of implants and therapies protects Smith & Nephew plc (SNN) from local crises. The solvency ratio confirms financial stability, with the indicator fixed at 1.09. This supports management's strategy to optimize sales and modernize products, leveraging a powerful patent shield and the deep integration of technologies into hospital surgical practices.

Growth in sports medicine sales and the implementation of robotics require high operational flexibility from Smith & Nephew plc (SNN). The quick ratio measures the company's ability to meet short-term obligations without relying on slow-moving inventory, utilizing only cash and accounts receivable. This quick ratio trend reflects the balance between protection against liquidity gaps and the risk of inflationary depreciation of excess cash. Investors view this indicator as confirmation of solvency during the development of new biomaterials.